GGrantIndex
Sort

40,608 grants matching prostate cancer

Molecular Imaging of Protein Glycosylation in Living Subjects

$380,796
Adam De La Zerda · Stanford University · DP5 · FY2013 · OD

Self-Concept Organization Across the Adult Life Span

$380,748
University Of Florida · R01 · FY2003 · AG

GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS

$380,741
Stanford University · R33 · FY2003 · CA

Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery

$380,729
Francis T.f. Tsai · Baylor College Of Medicine · R01 · FY2015 · GM

Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression

$380,688
Lorelei Mucci · Brigham And Women'S Hospital · R01 · FY2009 · CA

Understanding optimal delivery systems for cancer care

$380,646
David C Miller · University Of Michigan At Ann Arbor · R01 · FY2018 · CA

Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy

$380,625
Aria F Olumi · Massachusetts General Hospital · R01 · FY2014 · DK

Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy

$380,625
Aria F Olumi · Massachusetts General Hospital · R01 · FY2012 · DK

Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy

$380,625
Aria F Olumi · Massachusetts General Hospital · R01 · FY2015 · DK

Ethnicity & Determinants of QoL Following PCa Treatment

$380,622
Frank J Penedo · University Of Miami Coral Gables · R01 · FY2006 · CA

Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach

$380,616
Michael A Diefenbach · Feinstein Institute For Medical Research · R01 · FY2020 · CA

Androgen Signaling in Neoplastic Prostate Growth

$380,600
Fred Hutchinson Cancer Research Center · R01 · FY2005 · DK

Androgen Signaling in Neoplastic Prostate Growth

$380,600
Fred Hutchinson Cancer Research Center · R01 · FY2004 · DK

CANCER AND LEUKEMIA GROUP B

$380,576
University Of Chicago · U10 · FY2002 · CA

Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT

$380,536
Gary J Smith · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA

Analyses of human T regulatory cells

$380,517
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials

$380,463
Lorenzo Trippa · Dana-Farber Cancer Inst · R01 · FY2022 · LM

Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors

$380,399
Brian D Gonzalez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA

Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner

$380,350
Leanna J Standish · Bastyr University · U19 · FY2012 · AT

MOLECULAR CARCINOGENESIS IN THE MOUSE AND HUMAN PROSTATE

$380,335
Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA

VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer

$380,300
Mathew L Thakur · Thomas Jefferson University · R01 · FY2017 · CA

Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs

$380,298
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA

Role Of Lipids In Colon, Breast, And Other Cancers

$380,285
Thomas Eling · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Epithelial Stem Cell Programs

$380,250
Frank D. McKeon · Harvard Medical School · R01 · FY2008 · GM

Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model

$380,250
Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · AA